Acute UTIPRO & Protect capsules
Utipro ® acute & protect
3-fold strong for bladder infections. Acute, preventive and supportive effective.
Composition:
100 mg xyloglucan, 50 mg gelose, 100 mg propolis,
100 mg Hibiscus sabdariffa, silicon dioxide,
magnesium stearate (vegetable origin), corn starch
Intended use:
Utipro ® akut & protect is intended for the acute treatment and prevention of uncomplicated urinary tract infections (cystitis).
Dosage:
Acute intake:
2 capsules per day for 5 days 4
Preventive intake:
1 capsule per day for 15 days 4 (The treatment can be repeated if necessary.
Combination with antibiotics:
It is also advisable to take it in parallel with taking antibiotics1
bladder infection? Utipro ® acute & protect
✔ triple strength.
✔ Treat acute symptoms
✔ Prevent urinary tract infections
✔ Support antibiotic therapy
• Prevent: effectively reduces recurring urinary tract infections 1
• Treat: quickly relieves symptoms of acute bladder infections 2
• Support: also effective in addition to antibiotics 1
• Utipro ® akut & protect treats the cause in the intestine3and at the same time fights the pathogens in the bladder 2
• Suitable for every woman - with Utipro ® akut & protect women of all ages can get uncomplicated cystitis acutely and preventively under control. 5
Utipro ® acute & protect. 3 times stronger for cystitis. Treating acute symptoms, preventing recurring urinary tract infections and supporting antibiotic therapy:
by fighting the cause in the intestines and acidifying the urine in the bladder, Utipro ® akut & protect effectively prevents bacteria from multiplying. It can even supplement the antibacterial effect of an antibiotic1 and reduces the symptoms of cystitis after the first day of use.2
Use Utipro ® akut & protect for acute cystitis, to prevent recurring cystitis or in combination with an antibiotic.
1 Costache RC, et al.: Xyloglucan + Gelose Combination versus Placebo as Adjuvant Therapy to First-Line Antimicrobials for Uncomplicated Urinary Tract Infection in Adults. Urol Int. 2019;102(4):468-475.
2 García-Larrosa A et al.: Efficacy and safety of a med. device vs. placebo in the early treatment. of patients with symptoms of urinary tract infection. clinical Microbiol.2016: 233, 5.
3 Piqué N et al.: Xyloglucan, a Plant Polymer with Barrier Protective Properties. international J. Mol. Sci. 2018: 19, 673
4 lt. Instructions for use as of 03/2022
5 For persons under the age of 14 consult a doctor